Aareal Bank Q3 Consolidated Opt. Profit Surges

Aareal Bank AG (AAALF.PK) reported third-quarter consolidated operating profit of EUR 50 million compared to EUR 11 million last year.

Net interest income for the third quarter increased to EUR 155 million from EUR 128 million in the prior year period, driven by the expansion of the portfolio volume - in line with the strategy - and hence, of the interest-bearing business, as well as by the healthy margins for new business originated during the past quarters.

Net interest income rose significantly, despite the low interest rate environment - up 21% compared to the same quarter of the previous year, up 9% against the previous quarter.

Looking ahead, the company continues to anticipate a "swoosh"-shaped economic trend. However, Covid-19 case numbers have recently risen again in many countries, thus increasing uncertainty regarding the further development of the pandemic during the current winter quarter.

Based on these assumptions and current insights, Aareal Bank Group stated that it continues to expect a clearly positive consolidated operating profit in a range of between EUR 100 million and EUR 175 million for 2021 as a whole, whilst guidance for loss allowance remains unchanged.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT